Skip to main content
Clinical Trials/CTRI/2023/03/050501
CTRI/2023/03/050501
Completed
Phase 3

The effect of Bioactive Glass-Based and Epoxy Amine Resin Based root canal sealers on post-obturation pain in single-visit root canal treatment: A double blinded randomized controlled trial

Dr Ritesh Nagpal0 sites78 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Ritesh Nagpal
Enrollment
78
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 30, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Ritesh Nagpal

Eligibility Criteria

Inclusion Criteria

  • Good oral hygiene.
  • Patients had not used any analgesic in last 7 days.
  • Patients had not used any antibiotic in last 7 days.
  • Prolonged positive response to cold test (EndoIce; Coltene / Whaledent Inc, Cuyahoga Falls, OH) and electric pulp tester (Parkell, NY, USA).
  • Patients diagnosed with asymptomatic irreversible pulpitis caused by deep carious lesion without apical periodontitis on the mandibular first or second molar teeth.
  • The presence of profusely pulp bleeding with a thick consistency, which is exposed during caries removal.
  • Patients who had healthy periapical tissues (confirmed with periapical radiography).

Exclusion Criteria

  • Patients who refused to participate in this study.
  • Medically compromised patients (with immunosuppressive / systemic diseases, patients on medications).
  • Symptomatic or non\-vital teeth.
  • The presence of advanced periodontal disease (probing depth \> 4 mm).
  • The presence of open apex, presence of calcification, presence of resorption.
  • Patients who had multiple teeth requiring endodontic treatment.
  • Patients with allergic sensitivity to materials and agents that should be used during the root canal treatment.
  • Patients who had allergic sensitivity to local anaesthetics
  • Patients who had systemic or allergic sensitivity for the NSAIDs.
  • Pregnant patients and patients in lactation period.

Outcomes

Primary Outcomes

Not specified

Similar Trials